STOCK TITAN
  1. Home
  2. Sec-filings
  3. CTVA
  4. [8-K] Corteva, Inc. Reports Material Event

Corteva (NYSE: CTVA) lifts 2026 guidance and advances Vylor spin-off plan

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Corteva, Inc. reported second-quarter and first-half 2026 results and updated its 2026 outlook. For Q2 2026, net sales were $6,379 million, down 1% year over year, while non-GAAP Operating EBITDA rose 4% to $2.26 billion and Operating EPS increased 5% to $2.30. For the first half, net sales grew 4% to $11,284 million, GAAP income from continuing operations was $1.94 billion with EPS of $2.88, and non-GAAP Operating EBITDA and Operating EPS rose to $3.70 billion and $3.80 per share, up 10% and 14%.

Seed first-half net sales increased 4% to $7.56 billion and Operating EBITDA grew 11% to $3.00 billion, supported by 3% price/mix gains. Crop Protection first-half net sales rose 3% to $3.73 billion, with Operating EBITDA up 9% to $776 million despite pricing pressure in Latin America. Cash used in operating activities from continuing operations was $3,345 million for the first half versus $1,139 million in the prior-year period.

Reflecting the strong first-half performance, the company raised full-year 2026 guidance, now expecting non-GAAP Operating EBITDA of $4.1 billion to $4.3 billion and Operating EPS of $3.60 to $3.80 per share. Corteva also reaffirmed that it remains on track to complete the planned separation and Vylor spin-off on October 1, 2026, with key regulatory and governance milestones outlined.

Positive

  • Raised 2026 outlook with Operating EBITDA expected at $4.1–$4.3 billion and Operating EPS at $3.60–$3.80 per share, following strong first-half non-GAAP earnings growth.
  • Strong non-GAAP performance as first-half 2026 Operating EBITDA reached $3.70 billion and Operating EPS $3.80, up 10% and 14% versus 1H 2025, driven by Seed and Crop Protection margin expansion.

Negative

  • Significant cash outflow from continuing operations, with first-half 2026 operating cash flow of $(3,345) million versus $(1,139) million a year earlier, and cash, cash equivalents and restricted cash equivalents decreasing from $4,725 million to $2,619 million.

Filing Explained

As of June 30, Corteva reported more short-term borrowings than cash, while its planned separation remained incomplete for October 1.

Form 8-K reports specified material events; this filing furnishes Corteva’s second-quarter results and separation update. The separation remains planned rather than completed: final capital structures and an effective Form 10 are still expected before Vylor operates separately on October 1, 2026.

The results and schedules are furnished, not filed for purposes of Section 18 liability, and are not incorporated into another registration statement or filing except by specific reference.

Corteva says it has committed to restructuring activities expected to be substantially complete in 2028 and expects $140 million to $150 million of related net pre-tax charges during 2026. At June 30, 2026, it reported cash and cash equivalents, short-term borrowings, and long-term debt; operating activities used cash during the first six months.

The next stated separation checkpoints are approval of final capital structures, Form 10 effectiveness, investor events on September 15, 2026, and Vylor operating as a separate public company on October 1, 2026.

Item 0.08 Item 0.08
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q2 2026 net sales $6,379 million Three months ended June 30, 2026; down 1% vs Q2 2025
1H 2026 net sales $11,284 million Six months ended June 30, 2026; 4% growth vs 1H 2025
1H 2026 Operating EBITDA (non-GAAP) $3.70 billion Non-GAAP; up 10% vs first half 2025
1H 2026 Operating EPS (non-GAAP) $3.80 per share Non-GAAP; up 14% vs first half 2025
Full-year 2026 Operating EBITDA guidance $4.1–$4.3 billion Updated 2026 non-GAAP Operating EBITDA outlook
Full-year 2026 Operating EPS guidance $3.60–$3.80 per share Updated 2026 non-GAAP Operating EPS outlook
1H 2026 operating cash flow from continuing operations $(3,345) million Cash provided by (used for) operating activities – continuing operations
Cash, cash equivalents and restricted cash equivalents $2,619 million Balance at June 30, 2026
Operating EBITDA financial
"Operating EBITDA1 and Operating EPS1 were $3.70 billion, and $3.80 per share"
Operating EBITDA is a measure of the cash profit a company generates from its core business activities, calculated by taking earnings and adding back interest, taxes, depreciation and amortization while excluding one‑time items and non‑operating income. For investors it acts like checking how much money a store makes from selling its products before financing, taxes and accounting charges, helping compare operational performance across companies and periods.
Organic sales financial
"Organic1 sales increased 2% in the same period with gains in almost all regions"
Organic sales are the change in a company’s revenue that comes from its existing business operations, excluding effects of acquisitions, divestitures, and currency swings. Think of it like measuring how much a garden grows from the plants you already tended, rather than adding new pots; investors use organic sales to judge whether demand and core business performance are genuinely improving or if growth is driven by one‑time deals or accounting shifts.
Base income tax rate financial
"Base income tax rate is defined as the effective income tax rate less the effect of exchange"
AltEn facility remediation regulatory
"charge relating to the increase in the remediation accrual at the AltEn facility"
Form 10 regulatory
"Form 10 public filing available – due to regulatory requirements, Vylor is shown"
Form 10 is a U.S. Securities and Exchange Commission filing companies use to register their securities and become subject to public reporting requirements, delivering a comprehensive package of business descriptions, audited financial statements, management information and risk factors. For investors it matters because it creates a standardized, permanent dossier on a company—like a full inspection and disclosure packet when buying a house—so you can assess finances, risks and management and compare firms reliably.
Proposed Separation regulatory
"risks related to Corteva’s Proposed Separation, including, but not limited to, whether the objectives"
Q2 2026 net sales $6,379 million (1)% vs 2Q 2025
Q2 2026 Operating EBITDA (non-GAAP) $2.26 billion 4% vs 2Q 2025
1H 2026 net sales $11,284 million 4% vs 1H 2025
1H 2026 Operating EPS (non-GAAP) $3.80 per share 14% vs 1H 2025
Guidance

For full-year 2026, non-GAAP Operating EBITDA is expected to be $4.1–$4.3 billion and Operating EPS is expected to be $3.60–$3.80 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

How did Corteva (CTVA) perform financially in Q2 2026?
Corteva reported Q2 2026 net sales of $6,379 million, down 1% year over year, while non-GAAP Operating EBITDA increased 4% to $2.26 billion and Operating EPS rose 5% to $2.30, reflecting improved margins despite slightly lower sales.

What were Corteva (CTVA)’s first-half 2026 results?
For the first half of 2026, Corteva delivered net sales of $11,284 million, up 4% versus 1H 2025. Non-GAAP Operating EBITDA reached $3.70 billion and Operating EPS was $3.80, representing 10% and 14% growth, while GAAP EPS from continuing operations was $2.88.

How did Corteva’s Seed and Crop Protection segments perform in 1H 2026?
In 1H 2026, Seed net sales were $7.56 billion, up 4%, with Operating EBITDA of $3.00 billion, up 11%. Crop Protection net sales were $3.73 billion, up 3%, and Operating EBITDA was $776 million, up 9%, despite pricing pressure in Latin America.

What 2026 guidance did Corteva (CTVA) provide in this 8-K?
Corteva increased full-year 2026 guidance, expecting non-GAAP Operating EBITDA of $4.1–$4.3 billion and Operating EPS of $3.60–$3.80 per share, implying mid-single- to low-double-digit growth from 2025 based on its non-GAAP metrics.

What is happening with Corteva’s planned separation and Vylor spin-off?
Corteva stated it remains on track to complete the planned separation on October 1, 2026, when Vylor is expected to operate as a separate public company, following Form 10 effectiveness, final capital structure approvals, and investor day events.

What does the 8-K say about Corteva (CTVA)’s cash flow in 1H 2026?
For the first half of 2026, Corteva reported cash used in operating activities from continuing operations of $(3,345) million, compared with $(1,139) million in the prior-year period, alongside total cash, cash equivalents and restricted cash equivalents of $2,619 million at June 30, 2026.
false000175567200017556722026-07-302026-07-300001755672dei:OtherAddressMember2026-07-302026-07-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of Earliest Event Reported): July 30, 2026
Corteva, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware 001-38710 82-4979096
(State or other jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
 
9330 Zionsville Road,
Indianapolis, Indiana 46268
1000 N. West Street, Suite 900,
Wilmington, Delaware 19801
(Address of principal executive offices)(Zip Code)
 
(833) 267-8382
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share CTVA New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 2.02     Results of Operations and Financial Condition
On July 30, 2026, Corteva, Inc. (the “Company”) announced its consolidated financial results for the quarter ended June 30, 2026. A copy of the Company’s press release and financial statement schedules are furnished herewith on Form 8-K as Exhibits 99.1 and 99.2, respectively. The information contained in this report, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. In addition, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.


Item 9.01     Financial Statements and Exhibits

(d)    Exhibits.
99.1
Press Release dated July 30, 2026
99.2
Financial Statement Schedules dated July 30, 2026
104The cover page from the Company’s Current Report on Form 8-K, formatted in Inline XBRL







SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 Corteva, Inc.
 (Registrant)
  
 /s/ Brian Titus
 
 Brian Titus
 Vice President and Controller
 
July 30, 2026


1 News Release Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation • Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth • Crop Protection 1H demand for new products and focus on operational excellence helped offset competitive pricing dynamics • Full-year 2026 guidance3 increased to reflect strong first half performance, incremental benefits on controllable levers, and growth platforms • Corteva remains on-track to complete the planned separation, targeting October 1 Vylor spin-off date INDIANAPOLIS, Ind., July 30, 2026 – Corteva, Inc. (NYSE: CTVA) (“Corteva” or the “Company”) today reported financial results for the second quarter and six months ended June 30, 2026. 2Q 2026 Results Overview Net Sales Inc. from Cont. Ops (After Tax) EPS GAAP $6.38B $1.22B $1.81 vs. 2Q 2025 (1)% (12)% (10)% Organic1 Sales Operating EBITDA1 Operating EPS1 NON-GAAP $6.32B $2.26B $2.30 vs. 2Q 2025 (2)% 4% 5% 1H 2026 Results Overview Net Sales Inc. from Cont. Ops (After Tax) EPS GAAP $11.28B $1.94B $2.88 vs. 1H 2025 4% (5)% (3)% Organic1 Sales Operating EBITDA1 Operating EPS1 NON-GAAP $11.05B $3.70B $3.80 vs. 1H 2025 2% 10% 14% First Half 2026 Highlights • Net sales increased 4% versus prior year. Organic1 sales increased 2% in the same period with gains in almost all regions. • Seed net sales increased 4% and organic1 sales increased 3%. Price/mix was up 3% led by North America2 and EMEA2 with continued execution on the Company’s price for value strategy and increased royalty income. Volume was flat, primarily reflecting the shift from corn to soy in North America2 and timing shifts in Latin America. • Crop Protection net sales increased 3% and organic1 sales decreased 1%. Volume increased 2%, driven by demand for new products. Price declined 3% primarily due to the market dynamics in Latin America. • GAAP income and earnings per share (EPS) from continuing operations were $1.94 billion and $2.88 per share, respectively. • Operating EBITDA1 and Operating EPS1 were $3.70 billion, and $3.80 per share, respectively. • The Company updated full-year 2026 guidance3 and expects Operating EBITDA1 to be in the range of $4.1 to $4.3 billion. Operating EPS1 is expected to be $3.60 to $3.80 per share. 1. Organic Sales, Operating EPS, and Operating EBITDA are non-GAAP measures. See page 7 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 6 for further discussion. 4. One-time separation costs do not include deferred asset expenses related to debt issuance costs to be amortized/incurred as future interest payments.

 

News Release 2Q/1H 2026 2 “Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performance, combined with our company- wide focus on productivity, cost discipline and operational excellence, allowed us to deliver continued margin expansion. Given these results, and our confidence in the opportunities ahead, we are raising our full-year guidance. We also continue to make meaningful progress toward the planned separation, an important milestone that will create two focused, industry-leading companies with enhanced strategic flexibility and ambition to continue to create sustainable value for farmers, customers, shareholders, and employees. As we begin the second half of the year, our focus remains where it should be: on our customers, on delivering the year and on ensuring the separation on October 1 is both timely and smooth. I’m excited to see what the future holds for both companies.” Chuck Magro Chief Executive Officer Company Updates Separation Update: Key Milestone Targets • Corteva remains on track to complete the planned separation on October 1, 2026, with already announced key milestones o Appointment of both companies’ Board of Directors o Form 10 public filing available – due to regulatory requirements, Vylor is shown as the continuing operations of Corteva, Inc. with New Corteva presented as discontinued operations o Both companies reviewed capital structure submissions with the credit rating agencies o Net dis-synergies largely offset on run-rate basis; $25 million headwind included in full-year 2026 guidance given timing of separation-related activities • Key separation milestones expected to be achieved in the second half of 2026: o Board of Directors’ approval of final capital structures o Form 10 goes effective o Webcasted Investor Day events at New York Stock Exchange on September 15, 2026 o Vylor operating as separate public company on October 1, 2026

 

News Release 2Q/1H 2026 3 Summary of Second Quarter 2026 For the second quarter ended June 30, 2026, net sales decreased 1% versus the same period last year. Organic1 sales decreased 2%. Volume was down 3% versus prior year. Crop Protection volume decreased 2% over the prior year driven primarily by timing shifts in North America. Seed volume decreased 3% versus prior year due primarily to timing shifts in North America and Latin America, coupled with corn acre declines in North America and EMEA that were partially offset by higher soybean acres in North America and higher sunflower acres in EMEA. Price/mix was up 1% versus prior year, reflecting higher Seed pricing, partially offset by competitive price dynamics in Crop Protection, primarily in Latin America. GAAP income from continuing operations after income taxes was $1.22 billion in second quarter of 2026 compared to $1.38 billion in second quarter of 2025. Operating EBITDA1 for the second quarter of 2026 was $2.26 billion, up 4% compared to prior year, translating into over 190 basis points of Operating EBITDA1 margin improvement. 2Q 2Q % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change Net Sales $6,379 $6,456 (1)% (2)% North America $4,548 $4,629 (2)% (2)% EMEA $730 $747 (2)% (4)% Latin America $679 $672 1% (7)% Asia Pacific $422 $408 3% 8% 1H 1H % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change Net Sales $11,284 $10,873 4% 2% North America $6,987 $6,839 2% 2% EMEA $2,385 $2,224 7% 1% Latin America $1,185 $1,114 6% (3)% Asia Pacific $727 $696 4% 7%

 

News Release 2Q/1H 2026 4 Seed Summary Seed net sales were $4.53 billion in the second quarter of 2026, flat with the second quarter of 2025. This reflects a 3% increase in price/mix, offset by a 3% decrease in volume. The increase in price/mix is due primarily to demand for top technology and increased out-licensing income. Volume declines in the quarter were due to timing shifts in North America and Brazil, coupled with the acreage shift from corn to soy in North America and corn to sunflower in EMEA. Segment operating EBITDA was $1.97 billion in the second quarter of 2026, up 6% from the second quarter of 2025. Price/mix, reductions in net royalty expense, and ongoing cost and productivity actions more than offset lower volumes and increased R&D and functional cost. Segment operating EBITDA margin improved by over 230 basis points versus the prior-year period. 2Q 2Q % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change North America $3,955 $3,954 - % - % EMEA $272 $282 (4)% (4)% Latin America $160 $154 4% (5)% Asia Pacific $145 $147 (1)% 7% Total 2Q Seed Net Sales $4,532 $4,537 - % - % 2Q Seed Operating EBITDA $1,966 $1,863 6% N/A Seed net sales were $7.56 billion in the first half of 2026, up 4% from the same period of 2025. The sales increase reflects a 3% increase in price/mix and a 1% favorable currency impact. Price/mix gains in all regions, led by North America, demonstrate demand for top technology and the strength of the portfolio, coupled with increased out-licensing income. Volumes were flat, as higher soybean area in North America was offset by lower corn area in North America and timing shifts in Latin America. Favorable currency impacts were led by the Euro and the Brazilian Real, partially offset by the Turkish lira. Segment operating EBITDA was $3.00 billion for the first half of 2026, up 11% from the same period of 2025. Price/mix execution, reductions in net royalty expense, and ongoing cost and productivity actions more than offset increased selling, admin and R&D expense, including higher bad debt. Segment operating EBITDA margin improved by over 235 basis points versus the prior-year period. 1H 1H % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change North America $5,725 $5,551 3% 3% EMEA $1,200 $1,108 8% 3% Latin America $384 $339 13% 2% Asia Pacific $246 $246 - % 6% Total 1H Seed Net Sales $7,555 $7,244 4% 3% 1H Seed Operating EBITDA $3,000 $2,705 11% N/A

 

News Release 2Q/1H 2026 5 Crop Protection Summary Crop Protection net sales were approximately $1.85 billion in the second quarter of 2026 compared to approximately $1.92 billion in the second quarter of 2025. The sales decrease over the prior period reflects a 4% price decline and a 2% decrease in volume, partially offset by a 2% favorable impact from currency. The decrease in volume was driven primarily by channel purchase timing in North America, coupled with dry weather in EMEA and partially offset by broad-based volume growth in Asia Pacific. The price decline was primarily due to the competitive pricing environment in Latin America. Favorable currency impacts were led by the Brazilian Real and the Euro. Segment operating EBITDA was $342 million in the second quarter of 2026, up 2% from the second quarter of 2025. Cost and productivity actions along with currency more than offset the unfavorable impact of volume and price pressure. Segment operating EBITDA margin improved by over 110 basis points versus the prior-year period. 2Q 2Q % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change North America $593 $675 (12)% (12)% EMEA $458 $465 (2)% (4)% Latin America $519 $518 - % (7)% Asia Pacific $277 $261 6% 8% Total 2Q Crop Protection Net Sales $1,847 $1,919 (4)% (6)% 2Q Crop Protection Operating EBITDA $342 $334 2% N/A Crop Protection net sales were approximately $3.73 billion for the first half of 2026 compared to approximately $3.63 billion in the same period of 2025. The sales increase reflects a 2% increase in volume and a 4% favorable impact from currency, partially offset by a 3% decline in price. The price decline was primarily due to market dynamics in Latin America. The increase in volume was driven by demand for new products, partially offset by channel purchase timing in North America. Favorable currency impacts were led by the Euro and the Brazilian Real. Segment operating EBITDA was $776 million for the first half of 2026, up 9% from the same period last year. Cost and productivity actions, currency, and volume growth more than offset the unfavorable impact of price pressure and higher selling and admin expense. Segment operating EBITDA margin improved by over 120 basis points versus the prior-year period. 1H 1H % % ($ in millions, except where noted) 2026 2025 Change Organic1 Change North America $1,262 $1,288 (2)% (3)% EMEA $1,185 $1,116 6% (1)% Latin America $801 $775 3% (5)% Asia Pacific $481 $450 7% 7% Total 1H Crop Protection Net Sales $3,729 $3,629 3% (1)% 1H Crop Protection Operating EBITDA $776 $711 9% N/A

 

News Release 2Q/1H 2026 6 2026 Guidance Strong demand remains the defining feature of the agricultural landscape, supporting overall fundamentals across key crop markets. Farmers will continue to prioritize investments that enhance productivity and returns, driving adoption of advanced genetics, and differentiated crop protection products. While trade, currency movements, and weather will continue to influence market conditions, the overall environment remains grounded in durable end-market consumption. Against this backdrop, our full-year outlook remains positive. Seed demand continues to be supported by strong adoption of our differentiated technologies, while Crop Protection benefits from normalized channel inventories and improving industry fundamentals. Stabilizing farm economics continue to support farmer investment in solutions that drive yield improvement and profitability. As a result of these market dynamics and coupled with our strong first half execution, the Company increased full-year 2026 guidance3 with Operating EBITDA1 expected to be $4.1 billion to $4.3 billion, growth of 9% at the mid-point. Operating EPS1 is expected to be $3.60 to $3.80 per share, growth of 11% at the mid-point. The Company is not able to reconcile its forward-looking non-GAAP financial measures, to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as Significant Items, without unreasonable effort. Second Quarter Conference Call The Company will host a live webcast of its second quarter 2026 earnings conference call with investors to discuss its results and outlook tomorrow, July 31, 2026, at 9:00 a.m. ET. The slide presentation that accompanies the conference call is posted on the Company’s Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page. About Corteva Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com. Cautionary Statement About Forward-Looking Statements This press release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; sustainability targets and initiatives; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; the anticipated benefits, impacts, and timing of the Proposed Separation; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements. Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of the company's products; (ii) failure to successfully develop and commercialize the company's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of the company's biotechnology and other agricultural products; (iv) failure to comply with competition and antitrust laws; (v) effect of changes in agricultural and related policies of governments and international organizations; (vi) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (vii) effect of climate change and unpredictable seasonal and weather factors; (viii) effect of competition in Corteva's industry; (ix) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (x) risks related to recent funding and staff reductions at U.S. government agencies; (xi) risk related to geopolitical and military conflict; (xii) effect of volatility in Corteva's input costs; (xiii) risks related to Corteva's global operations; (xiv) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xv) risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the Corteva Separation; (xvi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xvii) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xviii) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xix) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xx) increases in pension and other post-employment benefit plan funding obligations; (xxi) risks related to pandemics or epidemics; (xxii) capital markets sentiment towards sustainability matters; (xxiii) Corteva’s intellectual property rights or defense against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) Corteva’s dependence on intellectual property cross-license agreements; (xxvi) risks related to Corteva’s Separation from DowDuPont; and (xxvii) risks related to Corteva’s Proposed Separation, including, but not limited to, whether the objectives of the proposed separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the proposed separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the proposed separation could divert the attention and time of the company’s management; the risk of any unexpected costs or expenses resulting from the proposed separation process or separation itself; and the risk of any litigation as a result of, or relating to, the Proposed Separation. Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” in Corteva’s annual and quarterly reports filed on Forms 10-K and 10-Q with the U.S. Securities and Exchange Commission.

 

News Release 2Q/1H 2026 7 Regulation G (Non-GAAP Financial Measures) This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures may include organic sales, organic growth (including by segment and region), operating EBITDA, operating earnings (loss) per share, and base income tax rate. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year over year results. These non-GAAP measures supplement the Company’s U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page A-5 of the Financial Statement Schedules. Corteva is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of the Company’s control, such as significant items, without unreasonable effort. For significant items reported in the periods presented, refer to page A-10 of the Financial Statement Schedules. Beginning January 1, 2020, the Company presents accelerated prepaid royalty amortization expense as a significant item. Accelerated prepaid royalty amortization represents the non-cash charge associated with the recognition of upfront payments made to Monsanto in connection with the Company’s non-exclusive license in the United States and Canada for Monsanto’s Genuity® Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. Due to the ramp-up of Enlist E3TM, Corteva significantly reduced the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter. The Company committed to restructuring activities to optimize the Crop Protection network of manufacturing and external partners, which are expected to be substantially complete in 2028. The Company expects to record approximately $140 million to $150 million net pre-tax restructuring charges during 2026 for these activities. Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items. Operating EBITDA is defined as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Non-operating benefits (costs) consists of non-operating pension and other post- employment benefit (OPEB) credits (costs), tax indemnification adjustments, and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the Company as pre-tax income or expense. Operating earnings (loss) per share is defined as “earnings (loss) per common share from continuing operations - diluted” excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the Company’s intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs. ® TM Corteva Agriscience and its affiliated companies. 7/30/2026 Media Contact Bethany Shively +1 804-866-2377 bethany.shively@corteva.com Investor Contact Kim Booth +1 302-485-3704 kimberly.a.booth@corteva.com

 

A-1
Corteva, Inc.
Consolidated Statements of Operations
(Dollars in millions, except per share amounts)
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Net sales$6,379 $6,456 $11,284 $10,873 
Cost of goods sold2,718 2,932 5,090 5,274 
Research and development expense388 375 729 710 
Selling, general and administrative expenses1,164 1,156 2,041 1,907 
Amortization of intangibles194 161 354 323 
Restructuring and asset related charges - net49 79 141 101 
Separation costs79 — 131 — 
Other income (expense) - net(115)103 (232)118 
Interest expense47 52 83 88 
Income (loss) from continuing operations before income taxes1,625 1,804 2,483 2,588 
Provision for (benefit from) income taxes on continuing operations408 422 541 539 
Income (loss) from continuing operations after income taxes1,217 1,382 1,942 2,049 
Income (loss) from discontinued operations after income taxes(52)(66)(54)(77)
Net income (loss)1,165 1,316 1,888 1,972 
Net income (loss) attributable to noncontrolling interests4 2 7 6 
Net income (loss) attributable to Corteva$1,161 $1,314 $1,881 $1,966 
Basic earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock from continuing operations$1.81 $2.02 $2.89 $2.99 
Basic earnings (loss) per share of common stock from discontinued operations(0.08)(0.10)(0.08)(0.11)
Basic earnings (loss) per share of common stock$1.73 $1.92 $2.81 $2.88 
Diluted earnings (loss) per share of common stock:
Diluted earnings (loss) per share of common stock from continuing operations$1.81 $2.02 $2.88 $2.98 
Diluted earnings (loss) per share of common stock from discontinued operations(0.08)(0.10)(0.08)(0.11)
Diluted earnings (loss) per share of common stock$1.73 $1.92 $2.80 $2.87 
Average number of shares outstanding used in earnings (loss) per share (EPS) calculation (in millions)
  Basic668.6681.7670.4683.3
  Diluted669.8683.1671.6684.7


A-2
Corteva, Inc.
Consolidated Balance Sheets
(Dollars in millions, except share amounts)
June 30, 2026December 31, 2025June 30, 2025
Assets
Current assets
Cash and cash equivalents$2,365 $4,521 $2,065 
Marketable securities— 9 76 
Accounts and notes receivable - net8,696 6,371 8,674 
Inventories4,443 5,667 4,316 
Other current assets853 767 873 
Total current assets16,357 17,335 16,004 
Investment in nonconsolidated affiliates145 160 134 
Property, plant and equipment9,744 9,551 9,455 
Less: Accumulated depreciation5,566 5,331 5,302 
Net property, plant and equipment4,178 4,220 4,153 
Goodwill10,437 10,465 10,518 
Other intangible assets8,006 8,301 8,583 
Deferred income taxes335 320 449 
Other assets2,184 2,044 1,918 
Total Assets$41,642 $42,845 $41,759 
Liabilities and Equity
Current liabilities
Short-term borrowings$3,193 $894 $1,942 
Accounts payable3,958 4,398 3,828 
Income taxes payable303 155 485 
Deferred revenue383 3,579 358 
Accrued and other current liabilities2,952 3,099 2,903 
Total current liabilities10,789 12,125 9,516 
Long-term debt1,682 1,686 1,687 
Other noncurrent liabilities
Deferred income tax liabilities512 251 258 
Pension and other post-employment benefits1,300 2,434 2,229 
Other noncurrent obligations1,956 1,963 1,918 
Total noncurrent liabilities5,450 6,334 6,092 
Commitments and contingent liabilities
Stockholders' equity
Common stock, $0.01 par value; 1,666,667,000 shares authorized; issued at June 30, 2026 - 667,018,000; December 31, 2025 - 672,163,000; and June 30, 2025 - 679,879,000
7 7 7 
Additional paid-in capital26,894 27,001 27,014 
Retained earnings (accumulated deficit)1,224 (67)1,532 
Accumulated other comprehensive income (loss)(2,966)(2,797)(2,644)
Total Corteva stockholders' equity25,159 24,144 25,909 
Noncontrolling interests244 242 242 
Total equity25,403 24,386 26,151 
Total Liabilities and Equity$41,642 $42,845 $41,759 

A-3
Corteva, Inc.
Consolidated Statements of Cash Flows
(Dollars in millions, except per share amounts)

Six Months Ended
June 30,
20262025
Operating activities
Net income (loss)$1,888 $1,972 
(Income) loss from discontinued operations after income taxes5477 
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation and amortization636 597 
Provision for (benefit from) deferred income tax232 (209)
Net periodic pension and OPEB (benefit) cost, net(5)19 
Pension and OPEB contributions(1,140)(84)
Net (gain) loss on sales of property, businesses, consolidated companies and investments6 (17)
Restructuring and asset related charges - net141 101 
Other net loss319 272 
Changes in assets and liabilities, net
         Accounts and notes receivable(2,416)(2,544)
         Inventories1,227 1,310 
         Accounts payable(487)(356)
         Deferred revenue(3,187)(2,944)
         Other assets and liabilities(613)667 
Cash provided by (used for) operating activities - continuing operations(3,345)(1,139)
Cash provided by (used for) operating activities - discontinued operations(12)(23)
Cash provided by (used for) operating activities(3,357)(1,162)
Investing activities
Capital expenditures(203)(212)
Proceeds from sales of property, businesses and consolidated companies - net of cash divested1 25 
Acquisitions of businesses - net of cash acquired(43)— 
Investments in and loans to nonconsolidated affiliates(6)— 
Proceeds from sales and maturities of investments9 62 
Proceeds from (payment for) settlement of net investment hedge— (56)
Other investing activities, net(5)(17)
Cash provided by (used for) investing activities(247)(198)
Financing activities
Net change in borrowings (less than 90 days)2,398 28 
Proceeds from debt868 1,214 
Payments on debt(989)(335)
Repurchase of common stock(500)(520)
Proceeds from exercise of stock options31 70 
Dividends paid to stockholders(241)(232)
Other financing activities, net(37)(38)
Cash provided by (used for) financing activities1,530 187 
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents(32)68 
Increase (decrease) in cash, cash equivalents and restricted cash equivalents(2,106)(1,105)
Cash, cash equivalents and restricted cash equivalents at beginning of period4,725 3,422 
Cash, cash equivalents and restricted cash equivalents at end of period$2,619 $2,317 

A-4
Corteva, Inc.
Consolidated Segment Information
(Dollars in millions, except per share amounts)

Three Months Ended
June 30,		Six Months Ended
June 30,
SEGMENT NET SALES - SEED2026202520262025
    Corn$2,868 $2,961 $5,241 $5,030 
    Soybean1,318 1,257 1,624 1,562 
    Other oilseeds228 186 473 409 
    Other118 133 217 243 
Seed$4,532 $4,537 $7,555 $7,244 
Three Months Ended
June 30,		Six Months Ended
June 30,
SEGMENT NET SALES - CROP PROTECTION2026202520262025
    Herbicides$932 $995 $1,959 $1,855 
    Insecticides399 436 776 772 
    Fungicides263 342 597 646 
    Biologicals86 97 156 181 
    Other167 49 241 175 
Crop Protection$1,847 $1,919 $3,729 $3,629 
Three Months Ended
June 30,		Six Months Ended
June 30,
GEOGRAPHIC NET SALES - SEED2026202520262025
North America 1
$3,955 $3,954 $5,725 $5,551 
EMEA 2
272 282 1,200 1,108 
Latin America160 154 384 339 
Asia Pacific145 147 246 246 
Rest of World 3
577 583 1,830 1,693 
Net Sales$4,532 $4,537 $7,555 $7,244 
Three Months Ended
June 30,		Six Months Ended
June 30,
GEOGRAPHIC NET SALES - CROP PROTECTION2026202520262025
North America 1
$593 $675 $1,262 $1,288 
EMEA 2
458 465 1,185 1,116 
Latin America519 518 801 775 
Asia Pacific277 261 481 450 
Rest of World 3
1,254 1,244 2,467 2,341 
Net Sales$1,847 $1,919 $3,729 $3,629 

1.Reflects U.S. and Canada
2.Reflects Europe, Middle East and Africa
3.Reflects EMEA, Latin America and Asia Pacific

A-5
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
Three Months Ended
June 30,		Six Months Ended
June 30,
20262026
Net Sales (GAAP)$6,379 $11,284 
Add: Impacts from Currency and Portfolio / Other(57)(236)
Organic Sales (Non-GAAP)$6,322 $11,048 
Three Months Ended
June 30,		Six Months Ended
June 30,
OPERATING EBITDA2026202520262025
Seed$1,966 $1,863 $3,000 $2,705 
Crop Protection342 334 776 711 
Corporate Expenses(47)(33)(77)(63)
Operating EBITDA (Non-GAAP)$2,261 $2,164 $3,699 $3,353 
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS AFTER INCOME TAXES TO OPERATING EBITDAThree Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Income (loss) from continuing operations after income taxes (GAAP)$1,217 $1,382 $1,942 $2,049 
Provision for (benefit from) income taxes on continuing operations408 422 541 539 
Income (loss) from continuing operations before income taxes (GAAP)1,625 1,804 2,483 2,588 
Depreciation and amortization339 301 636 597 
Interest income(27)(31)(61)(63)
Interest expense47 52 83 88 
Exchange (gains) losses - net 1
75 25 142 52 
Non-operating (benefits) costs - net 2
17 3 (1)13 
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges21 43 24 52 
Significant items (benefit) charge 3
85 (33)262 26 
Separation costs79 — 131 — 
Operating EBITDA (Non-GAAP)$2,261 $2,164 $3,699 $3,353 

1.Refer to page A-14 for pre-tax and after tax impacts of exchange (gains) losses.
2.Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) (credits) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
3.Refer to page A-10 for pre-tax and after tax impacts of significant items.

A-6
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Q2 2026 vs. Q2 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$(81)(2)%$(90)(2)%2 %(4)%— %— %
EMEA(17)(2)%(30)(4)%1 %(5)%2 %— %
Latin America7 1 %(45)(7)%(7)%— %8 %— %
Asia Pacific14 3 %31 8 %— %8 %(5)%— %
Rest of World4 — %(44)(2)%(2)%— %2 %— %
Total$(77)(1)%$(134)(2)%1 %(3)%1 %— %
SEED
Q2 2026 vs. Q2 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$1 — %$(7)— %2 %(2)%— %— %
EMEA(10)(4)%(10)(4)%3 %(7)%— %— %
Latin America6 4 %(7)(5)%7 %(12)%9 %— %
Asia Pacific(2)(1)%11 7 %8 %(1)%(8)%— %
Rest of World(6)(1)%(6)(1)%5 %(6)%— %— %
Total$(5)— %$(13)— %3 %(3)%— %— %
CROP PROTECTION
Q2 2026 vs. Q2 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$(82)(12)%$(83)(12)%— %(12)%— %— %
EMEA
(7)(2)%(20)(4)%(1)%(3)%2 %— %
Latin America1 — %(38)(7)%(10)%3 %7 %— %
Asia Pacific16 6 %20 8 %(5)%13 %(2)%— %
Rest of World10 1 %(38)(3)%(6)%3 %4 %— %
Total$(72)(4)%$(121)(6)%(4)%(2)%2 %— %

A-7
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SEED PRODUCT LINE
Q2 2026 vs. Q2 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$(93)(3)%$(103)(3)%4 %(7)%— %— %
Soybean61 5 %59 5 %(1)%6 %— %— %
Other oilseeds42 23 %40 22 %11 %11 %1 %— %
Other(15)(11)%(9)(7)%2 %(9)%(4)%— %
Total $(5)— %$(13)— %3 %(3)%— %— %
CROP PROTECTION PRODUCT LINE
Q2 2026 vs. Q2 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Herbicides$(63)(6)%$(85)(9)%(2)%(7)%3 %— %
Insecticides(37)(8)%(40)(9)%(6)%(3)%1 %— %
Fungicides(79)(23)%(87)(25)%(4)%(21)%2 %— %
Biologicals(11)(11)%(17)(18)%(8)%(10)%7 %— %
Other118 241 %108 220 %(18)%238 %21 %— %
Total$(72)(4)%$(121)(6)%(4)%(2)%2 %— %

1.Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-8
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Six Months 2026 vs. Six Months 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$148 2 %$131 2 %2 %— %— %— %
EMEA161 7 %26 1 %2 %(1)%6 %— %
Latin America71 6 %(28)(3)%(5)%2 %9 %— %
Asia Pacific31 4 %46 7 %1 %6 %(3)%— %
Rest of World263 7 %44 1 %— %1 %6 %— %
Total$411 4 %$175 2 %1 %1 %2 %— %
SEED
Six Months 2026 vs. Six Months 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$174 3 %$164 3 %2 %1 %— %— %
EMEA92 8 %33 3 %4 %(1)%5 %— %
Latin America45 13 %8 2 %8 %(6)%11 %— %
Asia Pacific— — %15 6 %8 %(2)%(6)%— %
Rest of World137 8 %56 3 %5 %(2)%5 %— %
Total$311 4 %$220 3 %3 %— %1 %— %
CROP PROTECTION
Six Months 2026 vs. Six Months 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$(26)(2)%$(33)(3)%— %(3)%1 %— %
EMEA
69 6 %(7)(1)%(1)%— %7 %— %
Latin America26 3 %(36)(5)%(10)%5 %8 %— %
Asia Pacific31 7 %31 7 %(4)%11 %— %— %
Rest of World126 5 %(12)(1)%(5)%4 %6 %— %
Total$100 3 %$(45)(1)%(3)%2 %4 %— %

A-9
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SEED PRODUCT LINE
Six Months 2026 vs. Six Months 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$211 4 %$132 3 %4 %(1)%1 %— %
Soybean62 4 %57 4 %— %4 %— %— %
Other oilseeds64 16 %54 13 %8 %5 %3 %— %
Other(26)(11)%(23)(9)%(3)%(6)%(2)%— %
Total $311 4 %$220 3 %3 %— %1 %— %
CROP PROTECTION PRODUCT LINE
Six Months 2026 vs. Six Months 2025Percent Change Due To:
Net Sales Change
(GAAP)
Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Herbicides$104 6 %$26 1 %(2)%3 %5 %— %
Insecticides4 1 %(14)(2)%(5)%3 %3 %— %
Fungicides(49)(8)%(82)(13)%(3)%(10)%5 %— %
Biologicals(25)(14)%(35)(19)%(6)%(13)%5 %— %
Other66 38 %60 34 %(7)%41 %4 %— %
Total$100 3 %$(45)(1)%(3)%2 %4 %— %

1.Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-10
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX)
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Seed$— $(1)$— $(41)
Crop Protection(67)37 (166)23 
Corporate(18)(3)(96)(8)
Total significant items before income taxes$(85)$33 $(262)$(26)
SIGNIFICANT ITEMS - PRE-TAX, AFTER TAX, AND EPS IMPACTS
Pre-tax
After tax 8
($ Per Share)
202620252026202520262025
1st Quarter
Restructuring and asset related charges - net 1
$(92)$(22)$(71)$(17)$(0.10)$(0.02)
Litigation settlement 2
(85)— (64)— (0.10)— 
   AltEn facility remediation charges 3
— (37)— (28)— (0.04)
   Income tax items 4
— — — 55 — 0.08 
1st Quarter – Total
$(177)$(59)$(135)$10 $(0.20)$0.02 
2nd Quarter
Restructuring and asset related charges - net 1
$(49)$(79)$(38)$(59)$(0.06)$(0.09)
Litigation settlement 2
(36)— (27)— (0.04)— 
Gain (loss) on sale of assets 5
— 14 — 12 — 0.02 
Insurance proceeds 6
— 98 — 74 — 0.11 
2nd Quarter – Total
$(85)$33 $(65)$27 $(0.10)$0.04 
Year-to-Date Total 7
$(262)$(26)$(200)$37 $(0.30)$0.05 

1.Second and first quarter 2026 include restructuring and asset related benefits (charges) of $(49) and $(92), respectively. The second quarter 2026 charges primarily relate to the Crop Protection Operations Strategy Restructuring Program. The first quarter 2026 charges primarily consist of ($78) related to the 2026 Restructuring Actions and ($14) related to the Crop Protection Operations Strategy Restructuring Program.

Second and first quarter 2025 include restructuring and asset related benefits (charges) of $(79) and $(22), respectively. The charges primarily relate to the Crop Protection Operations Strategy Restructuring Program.

2.Second and first quarter 2026 includes estimated settlement charges associated with various lawsuits filed in connection with the Federal Trade Commission investigation.

3.First quarter 2025 includes a charge relating to the increase in the remediation accrual at the AltEn facility consisting of Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans.

4.First quarter 2025 reflects a deferred tax benefit of $55 associated with a change in a legal entity's U.S. tax characterization.

5.Second quarter 2025 includes a benefit of $14 related to the 2022 Restructuring Actions consisting of a gain on the sale of assets.

6.The insurance proceeds include proceeds received related to prior significant items.

7.Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

8.Unless specifically addressed in notes above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

A-11
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
Operating Earnings (Loss) Per Share (Non-GAAP)
Operating earnings (loss) per share is defined as earnings (loss) per common share from continuing operations – diluted, excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting.
Three Months Ended
June 30,
2026202520262025
$$EPS (diluted)EPS (diluted)
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP)$1,213 $1,380 $1.81 $2.02 
Less: Non-operating benefits (costs), after tax 1
(51)(8)(0.08)(0.01)
Less: Amortization of intangibles (existing as of Corteva Separation), after tax(134)(110)(0.20)(0.16)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax(15)(33)(0.02)(0.05)
Less: Significant items benefit (charge), after tax(65)27 (0.10)0.04 
Less: Separation costs, after tax(65)— (0.09)— 
Operating Earnings (Loss) (Non-GAAP) 2
$1,543 $1,504 $2.30 $2.20 

Six Months Ended
June 30,
2026202520262025
$$EPS (diluted)EPS (diluted)
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP)$1,935 $2,043 $2.88 $2.98 
Less: Non-operating benefits (costs), after tax 1
(52)(16)(0.08)(0.02)
Less: Amortization of intangibles (existing as of Corteva Separation), after tax(240)(219)(0.35)(0.32)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax(18)(40)(0.03)(0.06)
Less: Significant items benefit (charge), after tax(200)37 (0.30)0.05 
Less: Separation costs, after tax(107)— (0.16)— 
Operating Earnings (Loss) (Non-GAAP) 2
$2,552 $2,281 $3.80 $3.33 

1.Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
2.Refer to page A-12 for the Non-GAAP reconciliation of operating EBITDA to operating earnings (loss) per share.

A-12
Corteva, Inc.
Operating EBITDA to Operating Earnings (Loss) Per Share
(Dollars in millions, except per share amounts)

Operating EBITDA to Operating Earnings (Loss) Per Share
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Operating EBITDA (Non-GAAP) 1
$2,261 $2,164 $3,699 $3,353 
Depreciation(145)(140)(282)(274)
Amortization of intangibles (post Corteva Separation)(20)(18)(41)(38)
Interest income27 31 61 63 
Interest expense(47)(52)(83)(88)
(Provision for) benefit from income taxes on continuing operations before significant items, separation costs, non-operating benefits (costs), amortization of intangibles (existing as of Corteva Separation), mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) 1
(466)(443)(675)(663)
Base income tax rate from continuing operations (Non-GAAP)1
22.4 %22.3 %20.1 %22.0 %
Exchange gains (losses), after tax 2
(63)(36)(120)(66)
Net (income) loss attributable to non-controlling interests(4)(2)(7)(6)
Operating Earnings (Loss) (Non-GAAP) 1
$1,543 $1,504 $2,552 $2,281 
Diluted Shares (in millions)669.8 683.1 671.6 684.7 
Operating Earnings (Loss) Per Share (Non-GAAP) 1
$2.30 $2.20 $3.80 $3.33 

1.     Refer to pages A-5 through A-9, A-11 and A-13 for Non-GAAP reconciliations.
2.     Refer to page A-14 for pre-tax and after tax impacts of exchange gains (losses).

A-13
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions)

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs.
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Income (loss) from continuing operations before income taxes (GAAP)
$1,625 $1,804 $2,483 $2,588 
Add: Significant items (benefit) charge 1
85 (33)262 26 
Separation costs79 — 131 — 
Non-operating (benefits) costs17 3 (1)13 
Amortization of intangibles (existing as of Corteva Separation)174 143 313 285 
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges21 43 24 52 
Less: Exchange gains (losses) 2
(75)(25)(142)(52)
Income (loss) from continuing operations before income taxes, significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP)
$2,076 $1,985 $3,354 $3,016 
Provision for (benefit from) income taxes on continuing operations (GAAP)
$408 $422 $541 $539 
Add: Tax (expenses) benefits on significant items (benefit) charge 1
20 (6)62 63 
Tax benefits on separation costs14 — 24 — 
Tax (expenses) benefits on non-operating (benefits) costs(34)(5)(53)(3)
Tax benefits on amortization of intangibles (existing as of Corteva Separation)40 33 73 66 
 Tax (expenses) benefits on mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges6 10 6 12 
Tax (expenses) benefits on exchange gains (losses) 2
12 (11)22 (14)
Provision for (benefit from) income taxes on continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP)
$466 $443 $675 $663 
Effective income tax rate (GAAP)
25.1 %23.4 %21.8 %20.8 %
Significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges effect(2.4)%(0.2)%(1.5)%2.0 %
Tax rate from continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges22.7 %23.2 %20.3 %22.8 %
Exchange gains (losses), net effect 2
(0.3)%(0.9)%(0.2)%(0.8)%
Base income tax rate from continuing operations (Non-GAAP)
22.4 %22.3 %20.1 %22.0 %

1.See page A-10 for further detail on the significant items table.
2.See page A-14 for further details of exchange gains (losses).

A-14
Corteva, Inc.
(Dollars in millions, except per share amounts)

Exchange Gains/Losses
The Company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)$4 $(154)$89 $(201)
Local tax (expenses) benefits(7)14 (31)13 
Net after-tax impact from subsidiary exchange gain (loss)$(3)$(140)$58 $(188)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)$(79)$129 $(231)$149 
Tax (expenses) benefits19 (25)53 (27)
Net after-tax impact from hedging program exchange gain (loss)$(60)$104 $(178)$122 
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)$(75)$(25)$(142)$(52)
Tax (expenses) benefits12 (11)22 (14)
Net after-tax exchange gain (loss)$(63)$(36)$(120)$(66)
As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

6 documents

Press Releases

Other Documents